Investing

Progyny : PGNY

PGNY

Stock Data

$18.60

$0.02 (0.11%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

HEALTHCARE PLANS

Progyny Inc is a New York-based company that provides innovative fertility and family building benefits solutions across the United States. It offers a unique approach to fertility care, combining personalized support with a selective network of specialists. Progyny's services extend beyond traditional fertility treatments to include pharmacy benefits and reimbursement programs for adoption, surrogacy, and related travel expenses. Originally known as Auxogyn, Inc., the company rebranded to Progyny, Inc. in 2015, continuing its mission to support individuals and couples on their journey to parenthood.

All Progyny Articles

1 Article

David Moadel | Mar 11, 2026 at 10:10 AM EDT

Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook

Two healthcare names are drawing fresh analyst attention this week as Wall Street recalibrates around a landmark GLP-1 truce and…